Carias Ann M, Anderson Meegan, McRaven Michael, Allen Edward, Fought Angela J, Hope Thomas J
Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA.
AIDS Res Hum Retroviruses. 2025 Mar;41(3):167-173. doi: 10.1089/aid.2024.0045. Epub 2024 Dec 12.
During male-to-female transmission, HIV-1 must cross the mucosal epithelium of the female reproductive tract to gain access to underlying target cells. Previously, we demonstrated that HIV-1 can penetrate intact columnar and squamous genital epithelia in both and systems. We found that the virus enters the squamous epithelium via a diffusion-based mechanism, but the mechanism of entry in columnar epithelium remained elusive. Using a similar set of approaches, we now demonstrate that HIV enters the endocervical simple columnar epithelium via endocytosis. By exposing human endocervical explant tissue to small molecule endocytosis inhibitors prior to virus exposure, we show that virus penetration into the simple columnar barrier is impeded. These data suggest a transcytosis-based mechanism for HIV-1 penetration into the endocervical columnar barrier.
在男性向女性传播过程中,HIV-1必须穿过女性生殖道的黏膜上皮才能接触到潜在的靶细胞。此前,我们证明了HIV-1在体外和体内系统中都能穿透完整的柱状和鳞状生殖上皮。我们发现病毒通过基于扩散的机制进入鳞状上皮,但进入柱状上皮的机制仍不清楚。使用类似的方法,我们现在证明HIV通过内吞作用进入宫颈单层柱状上皮。通过在病毒暴露前将人宫颈外植体组织暴露于小分子内吞抑制剂,我们发现病毒穿透单层柱状屏障受到阻碍。这些数据表明HIV-1穿透宫颈柱状屏障存在一种基于转胞吞作用的机制。